CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Gen-Os®; The soft lamina (OsteoBiol®)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04376060
NCT04376060N/ACompleted
CompareCT.gov

The Horizontal Ridge Augmentation Using Equine Xenograft and a Collagenated Porcine Cortical Lamina: A Clinical, Radiographic and Histological Prospective Study

Saint-Joseph University·interventional·Posted May 6, 2020·Updated Oct 12, 2020

In Brief

A clinical study evaluating Gen-Os®; The soft lamina (OsteoBiol®) for Horizontal Ridge Deficiency. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The primary aim of this study is to clinically, radiographically and histologically evaluate the lateral bone augmentation of the soft porcine cortical lamina (OsteoBiol®) using equine-derived bone particles (OsteoBiol®)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHorizontal Ridge Deficiency
CountriesLebanon
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 6, 2020
Enrollment StartApr 4, 2017
Primary CompletionJan 31, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.2 years ago

Interventions

Gen-Os®; The soft lamina (OsteoBiol®)device

The xenograft used in this study was the Gen-Os® by OsteoBiol; as described by the manufacturer, it is a carbonated nanocrystal bone mineral and collagen of natural heterologous origin, obtained by the treatment of cortical bone tissue of equine origins. Its granulometry ranges between 0.25 to 1 mm and it is described as being slightly radiopaque. The soft lamina (OsteoBiol®) used is a 35x35mm medium curved membrane of porcine origins. Its clinical indications as described by the fabricator: a co-adjuvant for the reconstruction or the partial or complete recovery of lost bone portions, fillers of non-infected, non-sclerotic and well blood bedewed bone defects.